The European Commission has not written off remdesivir to treat Covid-19, after the drug was distributed to tens of thousands of people - despite a recent statement from the World Health Organization (WHO) that the antiviral medicine is ineffective and should not be used.
"I will not get into a scientific analysis of remdesivir, this is for science to do that," said European Commission president Ursula von der Leyen on Friday (20 November), when pressed on the issue.
She noted con...
Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.
Already a member? LoginNikolaj joined EUobserver in 2012 and covers home affairs. He is originally from Denmark, but spent much of his life in France and in Belgium. He was awarded the King Baudouin Foundation grant for investigative journalism in 2010.
Nikolaj joined EUobserver in 2012 and covers home affairs. He is originally from Denmark, but spent much of his life in France and in Belgium. He was awarded the King Baudouin Foundation grant for investigative journalism in 2010.